An Exploratory Study of the Safety and Efficacy of a Trigonella foenum-graecum Seed Extract in Early Glucose Dysregulation: A Double-Blind Randomized Placebo-Controlled Trial
Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum...
Saved in:
Published in | Pharmaceutics Vol. 14; no. 11; p. 2453 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
14.11.2022
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG (p < 0.001), PPBG (p = 0.007) and triglycerides (p = 0.030) between treatment groups, with no changes in HbA1c (p = 0.41), FI (p = 0.12), PPI (p = 0.50) or C-peptide (p = 0.80). There was no difference in total cholesterol (p = 0.99), high-density lipoprotein (p = 0.35), low density lipoprotein (p = 0.60) or CRP (p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action. |
---|---|
AbstractList | Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG (p < 0.001), PPBG (p = 0.007) and triglycerides (p = 0.030) between treatment groups, with no changes in HbA1c (p = 0.41), FI (p = 0.12), PPI (p = 0.50) or C-peptide (p = 0.80). There was no difference in total cholesterol (p = 0.99), high-density lipoprotein (p = 0.35), low density lipoprotein (p = 0.60) or CRP (p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action. Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG ( p < 0.001), PPBG ( p = 0.007) and triglycerides ( p = 0.030) between treatment groups, with no changes in HbA1c ( p = 0.41), FI ( p = 0.12), PPI ( p = 0.50) or C-peptide ( p = 0.80). There was no difference in total cholesterol ( p = 0.99), high-density lipoprotein ( p = 0.35), low density lipoprotein ( p = 0.60) or CRP ( p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action. |
Author | Pickering, Emily Steels, Elizabeth Steadman, Kathryn J Rao, Amanda |
AuthorAffiliation | 2 Evidence Sciences Pty, Ltd., Brisbane, QLD 4005, Australia 1 School of Pharmacy, University of Queensland, Brisbane, QLD 4102, Australia 3 School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD 4102, Australia |
AuthorAffiliation_xml | – name: 1 School of Pharmacy, University of Queensland, Brisbane, QLD 4102, Australia – name: 2 Evidence Sciences Pty, Ltd., Brisbane, QLD 4005, Australia – name: 3 School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD 4102, Australia |
Author_xml | – sequence: 1 givenname: Emily orcidid: 0000-0002-7730-8164 surname: Pickering fullname: Pickering, Emily organization: Evidence Sciences Pty, Ltd., Brisbane, QLD 4005, Australia – sequence: 2 givenname: Elizabeth surname: Steels fullname: Steels, Elizabeth organization: Evidence Sciences Pty, Ltd., Brisbane, QLD 4005, Australia – sequence: 3 givenname: Amanda orcidid: 0000-0003-0090-9217 surname: Rao fullname: Rao, Amanda organization: School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD 4102, Australia – sequence: 4 givenname: Kathryn J orcidid: 0000-0001-7357-330X surname: Steadman fullname: Steadman, Kathryn J organization: School of Pharmacy, University of Queensland, Brisbane, QLD 4102, Australia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36432644$$D View this record in MEDLINE/PubMed |
BookMark | eNptUk1v1DAQjVARLaU_AWSJC5eAvxLHHJCW7VIqVQKx5WxNHDublRMvjoMafhS_EW-3VC3CF1szb968eZ7n2dHgB5NlLwl-y5jE73YbCD1oM8VOj4QTQnnBnmQnREqZc0nZ0YP3cXY2jlucDmOkYvJZdsxKzmjJ-Un2ezGg1c3O-QDRhxmt49TMyFsUNwatwZo4IxgatLK206BvU4CuQ9cmRc4Bst4MU5-3AYyeerQ2JoFvYgAdUZe4IbgZXbhJ-9Gg83kMpp0cxM4P79ECnfupdib_6LrU41tq5PvuV2L46tJ0tc-XfojBO5dCqSe4F9lTC240Z3f3afb90-p6-Tm_-nJxuVxc5brARcwLIaGqLW40hbrQtNFEMOBGCqELXkuKaVlDXVdMN1rakuiCEExpSTnDtCrZaXZ54G08bNUudD2EWXno1G3Ah1ZBSOY7ozQjwpa04EQAF5RCBaIAI4hJFlfcJq4PB67dVPem0SaNBO4R6ePM0G1U638qWcqKCpwI3twRBP9jMmNUfTfqvfuD8dOoqOB4rx-TBH39D3TrpzAkq_aoigmWhCZUcUDp4Mf0I_ZeDMFqv2DqvwuW6l49nOS-6u86sT9ff9N1 |
CitedBy_id | crossref_primary_10_1002_fsn3_3959 crossref_primary_10_1016_j_jaim_2023_100806 crossref_primary_10_2174_2210315513666230309105835 crossref_primary_10_3390_ijms25136987 crossref_primary_10_3390_ijms241813999 |
Cites_doi | 10.1016/B978-0-12-821038-3.00037-9 10.3892/mmr.2015.4298 10.1016/j.ctim.2020.102315 10.1155/2019/8507453 10.1371/journal.pone.0106039 10.1089/jmf.2008.0199 10.4103/ayu.AYU_209_15 10.4239/wjd.v6.i12.1207 10.1007/s11010-014-2152-x 10.1111/j.1601-5215.2007.00217.x 10.1007/s11655-007-9005-3 10.3390/biom9100551 10.1002/jsfa.7057 10.2174/1573401317666210706121806 10.1136/bmj.m2297 10.4314/ahs.v19i1.34 10.1016/j.ctim.2022.102852 10.1016/j.diabres.2019.03.038 10.1186/s40200-015-0208-4 10.1155/2016/7493694 10.1007/s00394-015-1037-4 10.3109/13880209.2013.826247 10.1024/0300-9831.79.1.34 10.1024/0300-9831/a000206 10.1038/ejcn.2016.148 10.3402/fnr.v60.32382 10.1016/j.jep.2016.08.003 |
ContentType | Journal Article |
Copyright | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | NPM AAYXX CITATION 3V. 7XB 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO GNUQQ GUQSH M2O MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.3390/pharmaceutics14112453 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea ProQuest Central Student Research Library Prep Research Library Research Library (Corporate) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: COVID name: Coronavirus Research Database url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/coronavirus sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1999-4923 |
ExternalDocumentID | oai_doaj_org_article_c317f625417a4722a8a75ae71e32684f 10_3390_pharmaceutics14112453 36432644 |
Genre | Journal Article |
GeographicLocations | Hong Kong China Australia Lantau Island |
GeographicLocations_xml | – name: Lantau Island – name: Hong Kong China – name: Australia |
GrantInformation_xml | – fundername: Gencor Pacific Ltd, Hong Kong – fundername: Gencor Pacific Ltd., Hong Kong – fundername: University of Queensland Graduate School |
GroupedDBID | --- 3V. 53G 5VS 8G5 AADQD ABDBF ABUWG ACGFO ACIHN AEAQA AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AZQEC BENPR BPHCQ CCPQU DIK DWQXO EBD ESX F5P FD6 GNUQQ GROUPED_DOAJ GUQSH GX1 HH5 HYE IAO IHR ITC KQ8 M2O M48 MK0 MODMG M~E NPM OK1 P6G PGMZT PIMPY PQQKQ PROAC RIG RNS RPM TR2 TUS AAYXX CITATION 7XB 8FK COVID MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c505t-579a8bf0dc2ab5c2dc173a4e977c54b92026babb83cdc9f61c511022624302863 |
IEDL.DBID | RPM |
ISSN | 1999-4923 |
IngestDate | Tue Oct 22 14:49:23 EDT 2024 Tue Sep 17 21:31:46 EDT 2024 Wed Dec 04 02:08:19 EST 2024 Mon Nov 18 17:51:01 EST 2024 Fri Dec 06 08:42:22 EST 2024 Sat Sep 28 08:19:17 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | post-prandial glucose Trigonella foenum-graecum fasting blood glucose type 2 diabetes insulin prediabetes fenugreek |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c505t-579a8bf0dc2ab5c2dc173a4e977c54b92026babb83cdc9f61c511022624302863 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-7730-8164 0000-0003-0090-9217 0000-0001-7357-330X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698270/ |
PMID | 36432644 |
PQID | 2748373254 |
PQPubID | 2032349 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c317f625417a4722a8a75ae71e32684f pubmedcentral_primary_oai_pubmedcentral_nih_gov_9698270 proquest_miscellaneous_2740511001 proquest_journals_2748373254 crossref_primary_10_3390_pharmaceutics14112453 pubmed_primary_36432644 |
PublicationCentury | 2000 |
PublicationDate | 20221114 |
PublicationDateYYYYMMDD | 2022-11-14 |
PublicationDate_xml | – month: 11 year: 2022 text: 20221114 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Pharmaceutics |
PublicationTitleAlternate | Pharmaceutics |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Verma (ref_20) 2016; 60 Fang (ref_34) 2016; 2016 Elsaadany (ref_35) 2022; 18 Geberemeskel (ref_27) 2019; 2019 ref_33 Rafraf (ref_11) 2014; 84 Yadav (ref_7) 2014; 52 Kassaian (ref_8) 2009; 79 Najdi (ref_15) 2019; 19 Losso (ref_9) 2009; 12 Verma (ref_16) 2015; 4 Kanat (ref_3) 2015; 6 Tharaheswari (ref_29) 2014; 396 Chakarova (ref_26) 2019; 151 Bhaktha (ref_10) 2011; 2 Gong (ref_18) 2016; 194 ref_23 ref_22 Cai (ref_2) 2020; 370 Gao (ref_30) 2015; 12 Ranade (ref_12) 2017; 38 Broca (ref_31) 1999; 277 ref_1 Gupta (ref_13) 2001; 49 Vuksan (ref_5) 2017; 71 Ng (ref_21) 2007; 19 (ref_25) 2022; 70 ref_28 Karim (ref_24) 2009; 62 Robert (ref_6) 2016; 55 Naidu (ref_32) 2015; 95 Lu (ref_14) 2008; 14 Hadi (ref_19) 2020; 49 ref_4 Gaddam (ref_17) 2015; 14 |
References_xml | – volume: 62 start-page: 315 year: 2009 ident: ref_24 article-title: Antidiabetic effects of exercise and fenugreek supplementation in males with NIDDM publication-title: Med. Dello Sport contributor: fullname: Karim – ident: ref_28 doi: 10.1016/B978-0-12-821038-3.00037-9 – volume: 12 start-page: 6555 year: 2015 ident: ref_30 article-title: 4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-alpha and regulating the expression of insulin signal transduction proteins publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2015.4298 contributor: fullname: Gao – volume: 49 start-page: 102315 year: 2020 ident: ref_19 article-title: The effect of fenugreek seed supplementation on serum irisin levels, blood pressure, and liver and kidney function in patients with type 2 diabetes mellitus: A parallel randomized clinical trial publication-title: Complement. Ther. Med. doi: 10.1016/j.ctim.2020.102315 contributor: fullname: Hadi – volume: 2019 start-page: 8507453 year: 2019 ident: ref_27 article-title: Antidiabetic effect of fenugreek seed powder solution (Trigonella foenum-graecum L.) on hyperlipidemia in diabetic patients publication-title: J. Diabetes Res. doi: 10.1155/2019/8507453 contributor: fullname: Geberemeskel – ident: ref_33 doi: 10.1371/journal.pone.0106039 – volume: 277 start-page: E617 year: 1999 ident: ref_31 article-title: 4-Hydroxyisoleucine: Experimental evidence of its insulinotropic and antidiabetic properties publication-title: Am. J. Physiol. contributor: fullname: Broca – volume: 12 start-page: 1046 year: 2009 ident: ref_9 article-title: Fenugreek bread: A treatment for diabetes mellitus publication-title: J. Med. Food doi: 10.1089/jmf.2008.0199 contributor: fullname: Losso – volume: 49 start-page: 1057 year: 2001 ident: ref_13 article-title: Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: A double blind placebo controlled study publication-title: J. Assoc. Physicians India contributor: fullname: Gupta – volume: 38 start-page: 24 year: 2017 ident: ref_12 article-title: A simple dietary addition of fenugreek seed leads to the reduction in blood glucose levels: A parallel group, randomized single-blind trial publication-title: Ayu doi: 10.4103/ayu.AYU_209_15 contributor: fullname: Ranade – volume: 6 start-page: 1207 year: 2015 ident: ref_3 article-title: Treatment of prediabetes publication-title: World J. Diabetes doi: 10.4239/wjd.v6.i12.1207 contributor: fullname: Kanat – volume: 396 start-page: 161 year: 2014 ident: ref_29 article-title: Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats publication-title: Mol. Cell Biochem. doi: 10.1007/s11010-014-2152-x contributor: fullname: Tharaheswari – ident: ref_1 – volume: 19 start-page: 304 year: 2007 ident: ref_21 article-title: The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure publication-title: Acta Neuropsychiatr. doi: 10.1111/j.1601-5215.2007.00217.x contributor: fullname: Ng – volume: 14 start-page: 56 year: 2008 ident: ref_14 article-title: Clinical observation on Trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus publication-title: Chin. J. Integr. Med. doi: 10.1007/s11655-007-9005-3 contributor: fullname: Lu – ident: ref_23 – ident: ref_4 doi: 10.3390/biom9100551 – volume: 95 start-page: 3177 year: 2015 ident: ref_32 article-title: Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet–streptozotocin-induced diabetic rats publication-title: J. Sci. Food Agri. doi: 10.1002/jsfa.7057 contributor: fullname: Naidu – volume: 18 start-page: 231 year: 2022 ident: ref_35 article-title: Antihyperglycemic effect of fenugreek and ginger in patients with type 2 diabetes: A double-blind, placebo-controlled study publication-title: Curr. Nutr. Food Sci. doi: 10.2174/1573401317666210706121806 contributor: fullname: Elsaadany – volume: 370 start-page: m2297 year: 2020 ident: ref_2 article-title: Association between prediabetes and risk of all cause mortality and cardiovascular disease: Updated meta-analysis publication-title: BMJ doi: 10.1136/bmj.m2297 contributor: fullname: Cai – volume: 19 start-page: 1594 year: 2019 ident: ref_15 article-title: A randomized controlled clinical trial evaluating the effect of Trigonella foenum-graecum (fenugreek) versus glibenclamide in patients with diabetes publication-title: Afr. Health Sci. doi: 10.4314/ahs.v19i1.34 contributor: fullname: Najdi – volume: 70 start-page: 102852 year: 2022 ident: ref_25 article-title: Effect of flaxseed (Linum usitatissimum) supplementation on glycemic control and insulin resistance in prediabetes and type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials publication-title: Complement. Ther. Med. doi: 10.1016/j.ctim.2022.102852 – volume: 151 start-page: 56 year: 2019 ident: ref_26 article-title: Assessment of glucose variability in subjects with prediabetes publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2019.03.038 contributor: fullname: Chakarova – volume: 14 start-page: 74 year: 2015 ident: ref_17 article-title: Role of fenugreek in the prevention of type 2 diabetes mellitus in prediabetes publication-title: J. Diabetes Metab. Disord. doi: 10.1186/s40200-015-0208-4 contributor: fullname: Gaddam – volume: 2016 start-page: 7493694 year: 2016 ident: ref_34 article-title: Diosgenin and 5-methoxypsoralen ameliorate insulin resistance through ER-α/PI3K/Akt-signaling pathways in HepG2 cells publication-title: Evid-Based Comp. Alt. Med. doi: 10.1155/2016/7493694 contributor: fullname: Fang – volume: 55 start-page: 2275 year: 2016 ident: ref_6 article-title: Reduction of postprandial blood glucose in healthy subjects by buns and flatbreads incorporated with fenugreek seed powder publication-title: Eur. J. Nutr. doi: 10.1007/s00394-015-1037-4 contributor: fullname: Robert – volume: 52 start-page: 243 year: 2014 ident: ref_7 article-title: Pharmacological effects of Trigonella foenum-graecum L. in health and disease publication-title: Pharm. Biol. doi: 10.3109/13880209.2013.826247 contributor: fullname: Yadav – volume: 79 start-page: 34 year: 2009 ident: ref_8 article-title: Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients publication-title: Int. J. Vitam. Nutr. Res. doi: 10.1024/0300-9831.79.1.34 contributor: fullname: Kassaian – volume: 84 start-page: 196 year: 2014 ident: ref_11 article-title: Effect of fenugreek seeds on serum metabolic factors and adiponectin levels in type 2 diabetic patients publication-title: Int. J. Vitam. Nutr. Res. doi: 10.1024/0300-9831/a000206 contributor: fullname: Rafraf – volume: 71 start-page: 234 year: 2017 ident: ref_5 article-title: Comparison of flax (Linum usitatissimum) and Salba-chia (Salvia hispanica L.) seeds on postprandial glycemia and satiety in healthy individuals: A randomized, controlled, crossover study publication-title: Eur. J. Clin. Nutr. doi: 10.1038/ejcn.2016.148 contributor: fullname: Vuksan – volume: 60 start-page: 32382 year: 2016 ident: ref_20 article-title: A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro) in patients with type 2 diabetes publication-title: Food Nutr. Res. doi: 10.3402/fnr.v60.32382 contributor: fullname: Verma – volume: 194 start-page: 260 year: 2016 ident: ref_18 article-title: Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysis publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2016.08.003 contributor: fullname: Gong – ident: ref_22 – volume: 2 start-page: 1231 year: 2011 ident: ref_10 article-title: Management of newly diagnosed diabetes by Trigonella foenum-graecum publication-title: Int. J. Res. Ayu. Pharm. contributor: fullname: Bhaktha – volume: 4 start-page: 2266 year: 2015 ident: ref_16 article-title: Clinical evaluation fenugreek seed extract in patients with type-2 diabetes: An add-on study in 154 patients publication-title: World J. Pharm. Res. contributor: fullname: Verma |
SSID | ssj0000331839 |
Score | 2.3444908 |
Snippet | Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy... Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 2453 |
SubjectTerms | Cardiovascular disease Clinical trials Diabetes Double-blind studies fasting blood glucose fenugreek Glucose Herbal medicine Insulin resistance Metabolism post-prandial glucose prediabetes Seeds Trigonella foenum-graecum type 2 diabetes |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqTr1UfXcLraZSxQmXJHYe7m2hUFSp1aosErfIT1gJEsRmD-FH8Rs7k4R9VEi99Gonjp0Z298k33xm7LNHCGqTYHiRqZxLGxtuvIy5EJmLXKEzYylR-Oev7ORM_jhPz9eO-iJOWC8P3L-4fYsbXECQLuNck7ChLnSeap_HXpBQSehW3yhZC6a6NViQr6o-ZUdgXL9_c7n6RDyPJcIMmYqNzajT7H8MaP7Nl1zbgI6fs2cDcoRx3-MX7ImvXrLdSf_Adg-mq0yq-R7swmQlSt2-YvfjCnq-XfdbHYg_2EIdAAEgnOrgmxZ05eCIJCWwParSMMXYvSYijIZQE2meX9xqbxfXcIq7HjbYUJIVzLBtEkqG7z0BHr61ONiL4WSwrzAGxOnmyvMDBLUOfuOD6uvZHbYwoa_4puaHPWP-CoumNCVes7Pjo-nhCR_OauAWMVTD01zpwoTI2UQbtL6zcS609AgvbSqNSjDWM9qYQlhnVchii0gP8UOWSIEQJxNv2FaFA3rHQGWecFwUXCikck5pEuVCnFSoNCR5PGJfHoxW3vSSHCWGMmTl8lErj9gBmXZ5MSlqdwXoZ-XgZ-W__GzEdh4coxym-bzEkB4DfIF3jdinZTVOUPrroitfL7prIhprhB1_2_vRsicC8SAh0hHLNzxso6ubNdXsshMBV5kqkjx6_z_Gts2eJpTVQexGucO2mtuF_4BYqzEfu2n1B7NfKwU priority: 102 providerName: Directory of Open Access Journals – databaseName: Coronavirus Research Database dbid: COVID link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5Be-HC-xEoaJFQT93U9q4fywWlaUtBAiKaot6sfaYRrR0S55D-KH4jM7aTkKriwNVrbWaiz7Pf7M58S8g7BxTURF6zLJEpEybUTDsRMs4TG9hMJdpgo_CXr8nJmfh8Hp-3G26ztqxyGRPrQG1Lg3vk-5A9QS7FIZ_5MPnF8NYoPF1tr9C4S7Y5UAdA-Hb_249Ph6tdloAjZmXTusMhv9-fXKy3imehALohYr6xKNXa_bcRzpt1k38tRMcPSL50oak_-dmdV7prrm-oO_6_jw_J_Zaj0l4Dqkfkjisek91B49Jijw7XPVuzPbpLB2v568UT8rtX0Kayrz7Ap1ipuKClp0A16anyrlpQVVh6hOIVMB8OKToEM0osuVHUl1iez0ZT5cz8ip7C-goTVtjORccwN0oy049NqT09XMDfOWrvIHtPexQyAn3p2AHQZ0u_ww-VV-NrmGGA5wW6ZP2mNv8SHg3x43tKzo6Phv0T1t4KwQywtYrFqVSZ9oE1kdKAM2vClCvhgMiaWGgZQVapldYZN9ZIn4QGOCUwlSQSHMhUwp-RrQIcekGoTBwyxsBbnwlprVQo_wWMLJOxj9KwQ7pLWOSTRvwjh6QJcZTfiqMOOUDwrF5G7e76QTkd5W0oyA1QNg9ppwhThVKdKlNprFwaOo7SO75DdpboyNuAMsvX0OiQt6thCAV4vqMKV87rdwL0NQDDnzdIXVnCgXki9-2QdAPDG6ZujhTji1puXCYyi9Lg5b_NekXuRdgZghWSYodsVdO5ew18rdJv2o_yD4O1R-U priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEF6VcuGCKE9DQYOEeqqL7fVrkRBKS0uFVBTRROrN2mcaKbVLHlLNj-I3MmM7CUHhwNVrj3c9M95vdme-ZeydRQiqI6f8PBWZH-tQ-crGoc95agKTy1RpKhS--JaeD-OvV8nVDlsSKnQfcLY1tKPzpIbTydHdj_oTOvxHijgxZH9_e71e_Z2FMSKIOOH32P0IJ0fK8rroEH_zc-ZkxKLZaxZ0vlrE27qef0vamLEaYv9taPTvpMo_ZqmzR-xhBy-h19rDHtux5WN20G9fWB_CYF1uNTuEA-ivmavrJ-xXr4Q2Ka_ZewdKMqyhcoAoES6ls_MaZGnglHgnUB41SRhggF9RtowEV1FmvT-aSqsXN3CJUyMKnFMlFoxRNrEpw5c2Sx4-1zjYUXd82AfoAYJ5NbH-MSJfA9_xRdXN-CdK6NNSv6r8kzatfoKXBuQ3T9nw7HRwcu53Bzr4GoHW3E8yIXPlAqMjqdBEjA4zLmOLGFQnsRIRBoRKKpVzbbRwaagRDiLISFGTiINS_oztljigFwxEagnsBc64PBbGCEnMXQimcpG4KAs9drRUWnHb8nYUGO-QloutWvbYMal2dTPRbjcXqumo6Ly40Ii2HEaMcZhJYtmUucwSabPQcmLNcR7bXxpGsTTlAuP-nGccn_LY21UzejFtzcjSVovmnoDGGmDHn7d2tOoJR9BIsNVj2YaFbXR1s6UcXzdM4SIVeZQFL__3Y7xiDyIq86B0x3if7c6nC_sawddcvWnc6Tf3uDJQ priority: 102 providerName: Scholars Portal |
Title | An Exploratory Study of the Safety and Efficacy of a Trigonella foenum-graecum Seed Extract in Early Glucose Dysregulation: A Double-Blind Randomized Placebo-Controlled Trial |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36432644 https://www.proquest.com/docview/2748373254 https://search.proquest.com/docview/2740511001 https://pubmed.ncbi.nlm.nih.gov/PMC9698270 https://doaj.org/article/c317f625417a4722a8a75ae71e32684f |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWS9NJL0XRVmhosUOQU2ZJILezNdpymBZwaiVPkJpAU6RiwJcPLwfmofmNnJNmOi5x6sQBRokjMjPmGevNEyFcDEFQHVrlJJGKXa1-5ynDfZSzKvCyRkdJYKNy_jq7u-M_78P6AhJtamJK0r9W4mU-mzXz8UHIrZ1Pd2vDEWoN-V0QiCWKvdUgOYfl9kqKXf78M3VRU1ToMUvrW7GG3O7zwOSAMHrK9daiU638OY_5LlXyy9ly-Jq9q0Ejb1eCOyYHJ35CzQfXA9Tkd7oqoFuf0jA52etTrt-RPO6cV1a58o06ROrimhaWA_eittGa5pjLPaA_VJKA_bJJ0CGl7gRwYSW2BfHl3NJdGr6b0FhY86HCJ9VV0DH2jRjL9XnHf6cUaJjuqPwr2jbYpQHQ1MW4H8GxGb-BBxXT8CD0McANfFW63IstP4NQQo-EdubvsDbtXbv2ZBlcDfFq6YSxkoqyX6UAqMHym_ZhJbgBZ6pArEUCap6RSCdOZFjbyNYA8gA5RwBmgm4i9J0c5TOgjoSIyCOE8m9mEiywTEvW4ACIlIrRB7DukuTFaOqvUOFLIYtDK6bNWdkgHTbu9GMW0yxPFfJTWLpVqwFAW8kDuxxK1M2Ui41Ca2DcMtXCsQ043jpHWEb5IIZuH3J7BXQ75sm2G2MQXLjI3xaq8xsO5ejDwD5UfbUfCAAoiGHVIvOdhe0Pdb4FwKPW_a_c_-e87P5GXAVZxIJuRn5Kj5XxlPgO2WqoGedHpXQ9u4Nj99fvHRaPco4DfPk8aZZz9BdgkL-o |
link.rule.ids | 230,314,727,780,784,864,885,2102,2221,21388,24318,27924,27925,33744,33745,38516,43805,43895,53791,53793,74302,74412 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lc9MwENZAeoAL74ehgJhheqpS25JfXJg0bUmhLRmaMr15JFlKM7R2SJxD-qP4jezaTkI6HQ5cLY-yynxefSvtfkvIBwMUVPtWsThMIia0p5gywmOch5mbxTJUGguFj0_C3pn4ch6cNwdu0yatcuETK0edFRrPyHcgeoJYikM882n8i2HXKLxdbVpo3CUb2MU7aJGN7rcfh3vLUxaXI2aTunSHQ3y_M75YHRVPPQF0QwR8bVOqtPtvI5w38yb_2ogOHpJ0sYQ6_-Rne1aqtr6-oe74_2t8RB40HJV2alA9JndM_oRs9eslzbfpYFWzNd2mW7S_kr-ePyW_OzmtM_uqC3yKmYpzWlgKVJOeSmvKOZV5RvdRvALmwyFJB2BGgSk3ktoC0_PZcCKNnl3RU9hfYcISy7noCOZGSWb6uU61p3tz-DuHTQ-yj7RDISJQl4btAn3O6Hf4oeJqdA0z9PG-QBWsW-fmX8KjAX58z8jZwf6g22NNVwimga2VLIgSGSvrZtqXCnCWaS_iUhggsjoQKvEhqlRSqZjrTCc29DRwSmAqoS84kKmQPyetHBb0ktAkNMgYXZvZWCRZlkiU_wJGBlCyfuQ5pL2ARTquxT9SCJoQR-mtOHLILoJn-TJqd1cPiskwbVxBqoGyWQg7hRdJlOqUsYwCaSLPcJTesQ7ZXKAjbRzKNF1BwyHvl8PgCvB-R-ammFXvuLhWFwx_USN1aQkH5onc1yHRGobXTF0fyUcXldx4EiaxH7mv_m3WO3KvNzg-So8OT76-Jvd9rBLBbEmxSVrlZGbeAHcr1dvmA_0DGDJK1Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLagkxAvaNzLBhgJ7WmmSZybeUHt1jJuVbV10t4iX7tKW1J6eQg_it_IOUnaUjTxGke-5JwTf8f-_JmQ9xYgqA6cYmksEhZqXzFlQ59xHhvPpDJWGg8K_xjGZ5fh16voquE_LRpa5fqfWP2oTaFxjbwD2RPkUhzymY5raBGj08Gn2U-GN0jhTmtzncZ9sgezohe0yF6vPxydb1ZcPI7-K-pjPBxy_c7sertsvPBDgB5hxHcmqErH_y7w-S-H8q9JabBPHjVoknZr8z8m92z-hByN6gbLYzrenq5aHNMjOtoKVZdPye9uTmsOXrXVTpFTWNLCUQCF9EI6uyypzA3to8wE1IdFko7hQxRIjpHUFUikZ5O5tHp1Sy9gJoQKl3jwik6hbhRPpp9rUjw9LWGwk-a2sI-0SwG7qxvLegB0DT2Hhorb6S-oYYQr-6pgJzWL_gYejTFMnpHLQX98csaa-xuYBly1ZFEiZKqcZ3QgFXiE0X7CZWgBcuooVCKA_E9JpVKujRYu9jWgP8AUcYD2S2P-nLRyGNBLQkVsEdt5zrg0FMYIiUJdgJ1SEbkg8dvkw9po2ayW6cggvUErZ3dauU16aNrNy6iyXT0o5pOsCdpMA7hykCCGfiJRVFOmMomkTXzLUSTHtcnh2jGyJvQX2dZR2-TdphiCFndiZG6LVfWOh2P1oOMvaj_a9IQDRkSU2ibJjoftdHW3JJ9eV8LgIhZpkHiv_t-tt-QBRE72_cvw2wF5GOBxDqQ1hoektZyv7GsAWUv1pomePzcsLBQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Exploratory+Study+of+the+Safety+and+Efficacy+of+a+Trigonella+foenum-graecum+Seed+Extract+in+Early+Glucose+Dysregulation%3A+A+Double-Blind+Randomized+Placebo-Controlled+Trial&rft.jtitle=Pharmaceutics&rft.au=Pickering%2C+Emily&rft.au=Steels%2C+Elizabeth&rft.au=Rao%2C+Amanda&rft.au=Steadman%2C+Kathryn+J.&rft.date=2022-11-14&rft.issn=1999-4923&rft.eissn=1999-4923&rft.volume=14&rft.issue=11&rft.spage=2453&rft_id=info:doi/10.3390%2Fpharmaceutics14112453&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_pharmaceutics14112453 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4923&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4923&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4923&client=summon |